Roshak A - Search Results

1

SB 203347, an inhibitor of 14 kDa phospholipase A2, alters human neutrophil arachidonic acid release and metabolism and prolongs survival in murine endotoxin shock.

Marshall LA, Hall RH, Winkler JD, Badger A, Bolognese B, Roshak A, Flamberg PL, Sung CM, Chabot-Fletcher M, Adams JL, et al. Marshall LA, et al. Among authors: roshak a. J Pharmacol Exp Ther. 1995 Sep;274(3):1254-62. J Pharmacol Exp Ther. 1995. PMID: 7562496

2

Evidence that 85 kDa phospholipase A2 is not linked to CoA-independent transacylase-mediated production of platelet-activating factor in human monocytes.

Winkler JD, Bolognese BJ, Roshak AK, Sung CM, Marshall LA. Winkler JD, et al. Among authors: roshak ak. Biochim Biophys Acta. 1997 Jun 2;1346(2):173-84. doi: 10.1016/s0005-2760(97)00032-5. Biochim Biophys Acta. 1997. PMID: 9219900

3

Modulation of human monocyte activities by tranilast, SB 252218, a compound demonstrating efficacy in restenosis.

Capper EA, Roshak AK, Bolognese BJ, Podolin PL, Smith T, Dewitt DL, Anderson KM, Marshall LA. Capper EA, et al. Among authors: roshak ak. J Pharmacol Exp Ther. 2000 Dec;295(3):1061-9. J Pharmacol Exp Ther. 2000. PMID: 11082441

4

Characterization of phospholipase A2 release by elicited-peritoneal macrophage and its relationship to eicosanoid production.

Marshall LA, Bolognese B, Roshak A. Marshall LA, et al. Among authors: roshak a. J Lipid Mediat Cell Signal. 1994 Sep;10(3):295-313. J Lipid Mediat Cell Signal. 1994. PMID: 7812679

5

Suppression of monocyte 85-kDa phospholipase A2 by antisense and effects on endotoxin-induced prostaglandin biosynthesis.

Roshak A, Sathe G, Marshall LA. Roshak A, et al. J Biol Chem. 1994 Oct 21;269(42):25999-6005. J Biol Chem. 1994. PMID: 7929310 Free article.

6

Effects of scalaradial, a type II phospholipase A2 inhibitor, on human neutrophil arachidonic acid mobilization and lipid mediator formation.

Marshall LA, Winkler JD, Griswold DE, Bolognese B, Roshak A, Sung CM, Webb EF, Jacobs R. Marshall LA, et al. Among authors: roshak a. J Pharmacol Exp Ther. 1994 Feb;268(2):709-17. J Pharmacol Exp Ther. 1994. PMID: 8113982

7

Coexistence of two biochemically distinct phospholipase A2 activities in human platelet, monocyte, and neutrophil.

Marshall LA, Roshak A. Marshall LA, et al. Among authors: roshak a. Biochem Cell Biol. 1993 Jul-Aug;71(7-8):331-9. doi: 10.1139/o93-050. Biochem Cell Biol. 1993. PMID: 8123250

8

Depletion of human monocyte 85-kDa phospholipase A2 does not alter leukotriene formation.

Marshall LA, Bolognese B, Winkler JD, Roshak A. Marshall LA, et al. Among authors: roshak a. J Biol Chem. 1997 Jan 10;272(2):759-65. doi: 10.1074/jbc.272.2.759. J Biol Chem. 1997. PMID: 8995361 Free article.

9

Inhibition of NFkappaB-mediated interleukin-1beta-stimulated prostaglandin E2 formation by the marine natural product hymenialdisine.

Roshak A, Jackson JR, Chabot-Fletcher M, Marshall LA. Roshak A, et al. J Pharmacol Exp Ther. 1997 Nov;283(2):955-61. J Pharmacol Exp Ther. 1997. PMID: 9353419

10

Cytosolic 85-kDa phospholipase A2-mediated release of arachidonic acid is critical for proliferation of vascular smooth muscle cells.

Anderson KM, Roshak A, Winkler JD, McCord M, Marshall LA. Anderson KM, et al. Among authors: roshak a. J Biol Chem. 1997 Nov 28;272(48):30504-11. doi: 10.1074/jbc.272.48.30504. J Biol Chem. 1997. PMID: 9374544 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31 results

Search Page

Filters